NCT03742154View on ClinicalTrials.gov

Hollings Cancer Center Varenicline Sampling Study

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

99

Participants

Timeline

Start Date

December 3, 2018

Primary Completion Date

April 6, 2020

Study Completion Date

April 6, 2020

Conditions
SmokingSmoking CessationSmoking, TobaccoSmoking, Cigarette
Interventions
DRUG

Varenicline 0.5 MG

varenicline comes in bottles of 56 - 0.5 mg pills

Trial Locations (1)

29425

Medical University of South Carolina, Charleston

All Listed Sponsors
lead

Medical University of South Carolina

OTHER

NCT03742154 - Hollings Cancer Center Varenicline Sampling Study | Biotech Hunter | Biotech Hunter